Benedicte Ballanger

Bron, 69500, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Reduced dorsal visual stream α2-adrenergic receptor availability is not associated with visuospatial impairment in Parkinson's disease.

Reduced dorsal visual stream α2-adrenergic receptor availability is not associated with visuospatial impairment in Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: May 07, 2026

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Journal: Current neurology and neuroscience reports

Published: February 13, 2026

Neuroimaging and Pathology Biomarkers in Parkinson's Disease and Parkinsonism.

Neuroimaging and Pathology Biomarkers in Parkinson's Disease and Parkinsonism.

Journal: Brain sciences

Published: December 24, 2025

Motor compensation in Parkinson's disease: an empirical challenge with clinical implications.

Motor compensation in Parkinson's disease: an empirical challenge with clinical implications.

Journal: Brain : a journal of neurology

Published: October 14, 2024

Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.

Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.

Journal: Brain : a journal of neurology

Published: June 27, 2023

Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.

Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.

Journal: Journal of neurology

Published: May 04, 2023

Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET.

Distribution of α2-Adrenergic Receptors in the Living Human Brain Using [11C]yohimbine PET.

Journal: Biomolecules

Published: April 27, 2023

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine.

Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine.

Journal: Cells

Published: July 12, 2022

The Human Basal Ganglia Mediate the Interplay between Reactive and Proactive Control of Response through Both Motor Inhibition and Sensory Modulation.

The Human Basal Ganglia Mediate the Interplay between Reactive and Proactive Control of Response through Both Motor Inhibition and Sensory Modulation.

Journal: Brain sciences

Published: March 25, 2021

Modeling [11C]yohimbine PET human brain kinetics with test-retest reliability, competition sensitivity studies and search for a suitable reference region.

Modeling [11C]yohimbine PET human brain kinetics with test-retest reliability, competition sensitivity studies and search for a suitable reference region.

Journal: NeuroImage

Published: February 16, 2021

Inhibitory control dysfunction in parkinsonian impulse control disorders.

Inhibitory control dysfunction in parkinsonian impulse control disorders.

Journal: Brain : a journal of neurology

Published: March 23, 2020

Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.

Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: October 23, 2018

Showing 1-12 of 30

Last Updated: 09/26/2026